유전자 편집 혁명 지도
CRISPR Decoded
유전 의학의 미래를 만들어가는 기술, 치료법, 질병, 과학자, 기업, 임상시험, 그리고 새로운 발견들을 살펴보세요.
지금 나의 출발점에서 시작하기
이 사이트는 매우 다양한 독자를 동시에 대상으로 합니다. 아래의 각 입구는 같은 데이터베이스로 다른 각도에서 들어가는 방법입니다. 쉽게 풀어쓴 내용도 없고, 생물학 학위를 전제로 하지도 않습니다.
유전자 편집 탐색하기
과학자들이 유전 물질을 변형하는 일곱 가지 방법입니다. 각 페이지는 쉬운 설명으로 시작해, 원하는 만큼 깊이 파고들 수 있습니다.
CRISPR-Cas9A protein that can be programmed with a short RNA guide to find one specific sequence in a genome and cut it.
Hiroshi Nishimasu, F. Ann Ran,... · CC BY-SA 3.0
Base EditingChemically converts one DNA letter into another at a chosen position, without cutting both strands of the double helix.
Prime EditingWrites a new stretch of DNA sequence directly into a chosen site, using a guide that carries the replacement text with it.
CRISPR-Cas12A family of CRISPR nucleases that cut DNA leaving staggered ends, use a different sequence requirement from Cas9, and can be smaller.
CRISPR-Cas13Targets RNA rather than DNA, so it can silence a gene's message without touching the genome itself.
Cas14 and miniature Cas systemsUnusually small CRISPR nucleases, roughly a third the size of Cas9, discovered in archaea and bacteriophages.
RNA EditingChanges letters in the RNA message rather than in the DNA, so the effect is real but temporary and the genome is untouched.
나란히 비교해보기정밀도, 절단 방식, 탑재 용량 크기, 전달 방법, 성숙도, 위험성
표적 질환
각 질환 페이지에는 유전자 편집이 승인된 치료법인지, 임상시험 중인지, 아직 실험실 단계에만 머물러 있는지가 명확하게 나와 있습니다.
Sickle Cell DiseaseBlood disorders
SpicyMilkBoy · CC BY-SA 4.0
Beta ThalassemiaBlood disorders
Dr Graham Beards · CC BY-SA 4.0
ATTR AmyloidosisMetabolic disease
Hereditary AngioedemaRare genetic disease
LucyHAE · CC BY-SA 3.0
High Cholesterol and Familial HypercholesterolemiaCardiovascular disease
CancerCancer
Mikael Häggström, M.D. Author info... · CC0
Leukemia and LymphomaCancer
https://wellcomeimages.org/indexplu... · CC BY 4.0
HIVInfectious disease
Photo Credit: C. Goldsmith
Content... · Public domain
Duchenne Muscular DystrophyMuscular disease
Dr. Edwin P. Ewing, Jr. · Public domain
Cystic FibrosisRare genetic disease
치료법들
모든 항목에 규제 현황이 명시된 약품 목록입니다.
CRISPR Decoded의 승인된 의약품: Casgevy (exagamglogene autotemcel) · Lyfgenia (lovotibeglogene autotemcel) · Zynteglo (betibeglogene autotemcel)
임상시험
근거가 실제로 만들어지는 곳.
알아두면 좋은 기업
누가 무엇을 만들고 있는지, 그리고 각 프로그램이 얼마나 진행되었는지.
이 분야를 바꾼 과학자들
각 사람이 실제로 기여한 내용, 이 분야에서 공로 인정은 논쟁 중이며, 저희는 해당 내용을 명시합니다.
Jennifer DoudnaStructural biochemist who, with Emmanuelle Charpentier, showed that Cas9 could be programmed with a single guide RNA to cut chosen DNA, and shared the 2020 Nobel Prize in Chemistry for it.
Christopher Michel · CC BY-SA 4.0
Emmanuelle CharpentierMicrobiologist who discovered tracrRNA, the missing component of the CRISPR-Cas9 system, and shared the 2020 Nobel Prize in Chemistry with Jennifer Doudna.
Bianca Fioretti, Hallbauer & Fioretti · CC BY-SA 4.0
Feng ZhangBioengineer who led one of the first demonstrations of CRISPR genome editing in human cells and discovered several new CRISPR systems including Cas12a and Cas13.
PuppyEggs · CC BY-SA 4.0
David LiuChemical biologist whose laboratory invented base editing and prime editing, the two techniques that changed gene editing from cutting to writing.
ServiceAT · CC BY-SA 4.0
George ChurchGeneticist whose laboratory independently demonstrated CRISPR editing in human cells in 2013, and a founder of an unusually large number of genomics companies.
Christopher Michel · CC BY-SA 4.0
Virginijus ŠikšnysLithuanian biochemist who independently showed that Cas9 could be programmed to cut DNA, publishing in 2012, and whose contribution is often omitted from popular accounts.
Gie2016 · CC BY-SA 4.0
최신 유전자 편집 뉴스
실명 출판사의 실제 기사들입니다. 모든 헤드라인은 원문으로 연결되며, 저희는 기사를 재작성하거나 재게재하지 않습니다.
Rice plants can fight off devastating disease after gene editing with AI-designed tool
University of Missouri researchers have created rice plants that resist bacterial blight, a devastating disease that threatens one of the world's most…
STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.
Bonjour Genomics: A Video from ASHG
GEN editors Uduak Thomas and Julianna LeMieux, PhD, recap ASHG, highlighting key sessions, Ultima Genomics’ user group meeting, Illumina news, and…
Artiva to wind down after two patient deaths in autoimmune cell therapy trials
Cell therapy biotech Artiva Biotherapeutics abruptly announced Tuesday morning that it is effectively shutting down and laying off almost all of its staff…
Outpace ends an ovarian cancer trial; Incyte data impresses at ESMO
Plus news about Genmab, Rumi, Prana and Fractyl. Outpace Bio ends cell therapy trial: The Seattle startup canned a Phase 1 ovarian cancer trial of its…
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is…
Spatial Proteomics for Precision Oncology
In this GEN webinar, Bernd Bodenmiller, PhD (University of Zürich), illustrates this integrated approach through two recent examples. The post Spatial…
CRISPR 설명
맨 처음부터 시작해 보세요. 생물학 배경 지식이 없어도 됩니다.